ICRF 159-induced cell-cycle perturbation in vitro: its relationship to inhibition of colony-forming ability. by Edgar, D. H. & Creighton, A. M.
Br. J. Cancer (1981) 44, 236
ICRF 159-INDUCED CELL-CYCLE PERTURBATION IN VITRO:
ITS RELATIONSHIP TO INHIBITION OF COLONY-FORMING ABILITY
D. H. EDGAR* AND A. M. CREIGHTON
From the Cellular Pharmacology and Antitumour Chemistry Laboratory,
Imperial Cancer Research Fund, London WC2A 3PX
Received 23 February 1981 Accepted 27 April 1981
Summary.-The effects of single doses of ICRF 159 (Razoxane) on the cell-cycle
kinetics of lines of BHK 21S cells in vitro were studied by means of flow micro-
fluorometry (FMF). A characteristic accumulation of cells in the 4n DNA region after
6 h in the presence of ICRF 159 was evident in cells which were sensitive to the cyto-
toxic effects of the agent, as judged by colony-forming assays. The subsequent
accumulation of 8n cells as the major population within 24 h indicates that this 6 h
effect is associated with the induction of tetraploidy through abnormal mitosis,
rather than reflecting a G2 block of potential value in combination therapy. In ICRF
159-resistant sublines, the cell-cycle distributions were similarly affected, but only by
doses ofthe drug high enough to reduce their surviving fraction. Somatic cell hybrids
from crosses between sensitive and resistant cells demonstrated intermediate
responses to ICRF 159, both in terms of cell-cycle kinetics and impairment of repro-
ductive integrity.
These data suggest a relationship between the 2 manifestations of the cellular
action of ICRF 159, and also a possible predictive role for FMF in the assessment of
response to this particular agent.
THE TECHNIQUE of flow microfluoro-
metry (FMF) has been applied extensively
in recent years to the study of the cell-
cycle kinetics of populations of cells and
the perturbations induced by chemo-
therapeutic agents in such populations
(Raju et al., 1980). The data obtained are
potentially useful in 2 main ways. First,
if an agent can be shown to induce
a redistribution of cells with respect to the
phases ofthe cell cycle, this may clarify its
role in combination therapy schedules.
Secondly, in cases where a drug-induced
perturbation of the cell cycle reflects an
impairment of reproductive integrity,
FMF may be ofpotential use in predicting
sensitivity to the cytotoxic effects of the
agent.
The present report demonstrates that
the antitumour agent ICRF 159 induces a
characteristic perturbation in the cell-
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cycle kinetics of lines of BHK 21S cells
with varying degrees of sensitivity to the
drug, which appears to correlate with the
survival response as judged by clonogenic
assays. This suggests that sensitivity to
ICRF 159 may be fairly accurately
predicted from FMF studies. These studies
have the advantages of being simple to
perform and providing an answer very
rapidly, in contrast to the more laborious
colony-forming assays which take at least
5 days to provide results. A preliminary
report of some of these results has been
presented (Edgar & Creighton, 1980).
MATERIALS AND METHODS
ICRF 159.-ICRF 159 (Razoxane, NSC
129943) was synthesized in this laboratory
and dissolved in sterile 0.9%0 (w,/v) saline
immediately before addition to cell cultures.
Cell culture.-BHK 21S/TK- was a subline
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ofBHK 21S cells (Capstick et al., 1966) which
had been selected for resistance to 5-
bromodeoxy-uridine (30 ,g/ml). BS/159-1/
HGPRT- and BS/159-4/HGPRT- were sub-
lines of 2 independently-derived ICRF 159-
resistant lines (White & Creighton, 1976;
White, 1979) which had been additionally
selected for resistance to 6-thioguanine (10
,tg/ml). C2 and D2 were somatic-cell hybrid
clones from polyethylene glycol (PEG)-in-
duced crosses, using BHK 21S/TK- as the
sensitive parent and BS/159-1/HGPRT- and
BS/159-4/HGPRT- respectively as the ICRF
159-resistant parents (Edgar, 1980; Edgar &
Creighton, in preparation).
Cells were grown in 50 mm-diameter Petri
dishes (A/S Nunc, Denmark) in Dulbecco's
modification of Eagle's minimal essential
medium supplemented with 10% foetal calf
serum (Gibco Europe, Glasgow, Scotland). All
cell lines had approximate population-doub-
ling times of12 h when in exponential growth,
and plating efficiencies of between 35 and
45%.
Colony-forming assays.-In order to assess
the effects of single doses of ICRF 159 on the
reproductiveintegrity ofcells, - 400 cells from
exponentially-growing asynchronous cultures
were seeded into 50 mm-diameter Petri dishes
and 3 h later the appropriate dose ofthe agent
was added to triplicate cultures. After 6 days
incubation, the resultant colonies were fixed
and stained using Leishman's stain, and the
number of colonies containing at least 50
apparently normal cells was counted micro-
scopically. Although the drug was present
throughout this period, its concentration will
have fallen fairly rapidly, with a half-life of
about 12 h under the conditions ofincubation.
The mean number ofcolonies in triplicate cul-
tures was recorded and cell survival of the
treated cells was expressed as a percentage of
the mean number of colonies in control
dishes.
Flow mtcrofluorometry (FM71F).-Cells for
FMF analysis were harvested and stained
according to the method ofCrissman & Tobey
(1974) exceptthattheconcentrationofmithra-
mycin used was 50 ,ug/ml. DNA histograms
were obtained by means of a fluorescence-
activated cell sorter (FACS-1, Becton Dickin-
son, California, U.S.A.) with excitation at
457 nm and a Ditric Optics 520 nm "cut on"
interference filter, together with a 520 Series
D coloured glass filter in the fluorescence
channel. Histograms obtained from hybrid
cells, which had twicethe DNAcomplement of
the parents, were normalised for comparison
byrealigning the outputoftheFACS-1 insuch
awaythatthe GI peak ofthehybridsappeared
inthe same fluoresence channel as the GI peak
of the parents. All FMF analysis was carried
out on exponentially-growing asynchronous
cultures containing 5 x 105 cells/50 mm-
diameter dish.
RESULTS
The response of sensitive, resistant and
hybrid cells to ICRF 159, as judged by
colony-forming survival assays, is shown
in Fig. 1. ICRF 159 can be seen to induce a
dose-dependent inhibition of survival in
all 3 cell types, with the hybrid responses
being intermediate between those of the
relevant parents.
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FIG. 1.-Effect of continuous exposure to
ICRF 159 on the colony-forming ability of
BHK 21S/TI- (*), BS/159-1/HGPRT-
(*), BS/159-4/HGPRT- (LC:), hybrid C2
(-) and D2 (A).
The gradation in response to ICRF 159
within these cell types suggested that this
might be a suitable model system in which
techniques such as FMF could be used to
detect possible early predictive markers of
response to this agent in terms of cell
survival. It was therefore first necessary to
select a suitable criterion for cell-cycle
kinetic response to ICRF 159, using FMF.
The effects of 12-5 ,ug/ml ICRF 159 on
BHK 21S/TK- cells are shown in Fig. 2.
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the emergence oftetraploid cells, is seen to
predominate. Since the cells must com-
plete a further round of DNA synthesis to
achieve an 8n DNA complement, the
accumulation of 4n cells at 6 h cannot re-
flect a "block" in cell-cycle traverse ofany
significant duration but must again indi-
eate a transient state (see Discussion
below). This accumulation seemed to be
the most characteristic aspect of the
kinetic effects of ICRF 159, and as
such was adopted as a parameter for
the assessment of kinetic response in the
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FiG. 2. Effect of continuous exposure to
ICRF 159 (12-5 ,ug/ml) on the cell-cycle
distribution of BHK 21S/TK- cells at
various times after administration.
This concentration of the drug was chosen
since, by slightly exceeding the minimum
dose for >99%0 inhibition of colony-for-
ming ability in these cells, it ensures that
virtually all the cells in the population are
destined to become non-viable. Therefore,
the kinetic effects seen are potential
reflections of the cyto-toxic action of
ICRF 159. After 3 h in the presence of
ICRF 159, an accumulation of cells both
in S-phase and the 4n DNA peak can be
seen to occur. However, the S-phase
accumulation appears to be transient, as
there is almost complete accumulation of
cells in the 4n DNApeak after 6 h. Twenty-
four hours after the administration of
ICRF 159, an 8n DNA peak, illustrating
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FIa. 3. Effect of 6 h exposure to ICRF 159
on the cell-cycle distribution of [A] BHK
21S/TK-, [B] hybrid C2 and [C] BS/159-1/
HGPRT. Numbers given above indicate %
cell survival at equivalent concentrations in
colony-forming assays in the continuous
presence of the agent for the same cell lines.
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investigation of the relationship between
cell-cycle kinetic changes and the effects on
colony-forming ability induced by this
agent.
To examine the relationship between
cell-cycle perturbation and inhibition of
cell survival, concentrations of ICRF 159
were chosen which produced a range of
effects on cell survival in sensitive,
resistant and hybrid cells. Treatment with
12*5 jtg/ml ICRF 159 inhibited survival
virtually completely in sensitive cells, but
had negligible effects on the colony-
forming ability of resistant and hybrid
cells. At a concentration of50,ug/ml, ICRF
159 again completely inhibited the clono-
genic potential of BHK 21S/TK- cells but
in this case also had a marked effect on the
hybrid cells( 500% inhibition of survival)
and also induced a small degree of cell kill
in resistant cells. The highest concentration
(100 ,ug/ml) induced 82 and 75%0 inhibition
of colony-forming ability in hybrids C2
and D2 respectively, and also significantly
reduced the survival of resistant cells.
Sensitive cells were again completely in-
hibited at the high dose.
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FIG. 4. Relationship between 00 cell survival
and the increase in 0 area of the second
(4n) peaks of the DNA histograms for BHK
21S/TK- ( ), BS/159-1/HGPRT- (U),
BS/159-4/HGPRT- (Li), hybrid C2 (A)
and hybrid D2 (A).
The DNA histograms obtained after 6 h
in the presence ofthe above doses of ICRF
159 from BHK 21S/TK-, BS/159-1/
HGPRT- and hybrid C2, are shown in
Fig. 3. When the accumulation of 4n cells
is examined, it can be seen that this only
occurred in all 3 cell lines at doses which
also markedly reduced the surviving cell
fraction, and also that its extent increased
with increasing inhibition of colony-
forming ability. If the percentage of cell
survival is plotted against the percentage
area under the second (4n) peak, there is a
fairly good linear relationship for those
responses where measurable survival was
observed, i.e., > 1% (Fig. 4). Therefore, by
examiningthe FMF dataalone itispossible
to distinguish at appropriate doses, cells of
differing sensitivity to ICRF 159 in terms
of inhibition of survival.
The corresponding DNA histograms for
BS/159-4/HGPRT- and the hybrid D2
cells are virtually identical to those of
the first series and are not reproduced.
There is, however, a similar reduction of
colony-forming ability which also parallels
the changes in cell-cycle distribution
(Fig. 4).
DISCUTSSION
The view that cell-cycle kinetic effects
of cancer chemotherapeutic agents may
be of use in the determination oftheir role
in therapy has received much attention in
recent years (see Hill (1978) for review).
The relatively rapid information con-
cerning the effects of drugs on cell-cycle
kinetics which can be obtained by means
of flow microfluorometry (FMF) has led
to this technique being widely applied by
those interested in the role of cell kinetics
in the chemotherapy of malignant disease
(Tobey et al., 1979).
In this report we have demonstrated
that a cell-cycle kinetic perturbation
induced by the antitumour agent ICRF
159 within 6h of drug addition and
detectable by FMF, shows a correlation
with inhibition of colony-forming ability
in cell lines with a range of sensitivities to
n I I
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the drug. This type of correlation has been
demonstrated in vitro with adriamycin-
sensitive and resistant cells (Raju et al.,
1980) and in vivo using mouse leukaemia
cells with varying sensitivity to 1-f-D-
arabinofuranosylcytosine (Alabaster &
Bunnag, 1976).
Using FMF, it had earlier been shown
(Creighton, 1979) that ICRF 159 induces
dose-dependent perturbations of the cell
cycle of mouse L cells in culture. The
establishment of a correlation between
FMF and cytotoxic response in the case of
ICRF 159 suggests that the charac-
teristic perturbation of the cell cycle
which results in the transient accumu-
lation of 4n cells is closely related to the
molecular mechanism of cell killing by the
agent, since White (1979) has shown that
resistance to ICRF 159 in the cells used in
this study is not due to impaired uptake of
the drug. The correlation is not surprising,
in view ofthe fact that the 4n populations
are largely composed oftetraploid GI cells
resulting from abnormal mitoses (Creigh-
ton, 1979) and are later replaced as the
major peaks by 8n populations (Fig. 2).
Tobey et al. (1978) have pointed out that
drug-induced tetraploid cells are normally
among the first to die out in a drug-
treated population.
If of wider applicability, this relation-
ship means that the early detection of
response or lack of response to ICRF 159
by FMF could play a role as a prognostic
factor in clinical situations. Indeed the
utility of FMF as a prognostic clinical tool
in monitoring response to chemotherapy
(including ICRF 159) has been suggested
in certain tumours by the work of Smets
et at. (1976) and Cullen & Capellaro (1978).
However, the potential use ofICRF 159 as
a synchronising agent in combination
chemotherapy would appear to be un-
likely from the results presented in this
report, since perturbations in the cell-
cycle kinetics only seem to parallel the loss
of cell viability.
The authors gratefully acknowledge the help of D.
Delia with the flow microfluorometric analyses.
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